Tresivac Vaccine Substitute

Substitutes of Tresivac Vaccine meet the same safety and efficacy standards as Tresivac Vaccine , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Tresivac Vaccine may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Tresivac Vaccine if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Tresivac Vaccine for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Tresivac Vaccine is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Tresivac Vaccine to its substitute. Always consult your doctor before switching.

Tresivac Vaccine is a vaccine or an immunizing agent which is made from a live, and weakened or attenuated virus. It helps to provide protection by stimulating the immune system to form antibodies that act against the measles, mumps and rubella viruses.

Rubella is also known as German Measles. It is a mild disease whose symptoms include a characteristic red rash, fever and swollen lymph nodes.

A single dose of vaccine is 93% effective against measles, 78% effective against mumps, and 97% effective against rubella. The vaccine is 97% effective against measles and 88% effective against mumps after two doses.

Rubella/German measles is a milder form of measles. Measles always manifests as high fever and swollen lymph nodes, whereas the fever is of low grade in Rubella and lymph nodes are not always swollen. The pattern of rash is also different in the two diseases. The rash is spotty in Rubella, whereas it is blotchy in measles.

Tresivac Vaccine can be given till five years of age in children as a part of routine immunisation. However, always follow the regular schedules and do not delay vaccination. If the vaccine was missed in childhood, it could be given to adults in a one or two-dose regimen.

Tresivac Vaccine should not be used in individuals with a weak immune system due to diseases (cancer or HIV) or medicines (immune suppressants), blood disorders, immunological diseases, active untreated tuberculosis, and severe illness with fever.

Measles is an infectious viral disease. A virus in the paramyxovirus family causes it. It is typically transmitted through direct contact and the air. Measles symptoms appear one week to two weeks after contact with the virus. Symptoms include high fever, cough, runny nose, and watery eyes.

Store Tresivac Vaccine in 2°C - 8°C temperatures. Keep the vial in the outer carton to protect it from light. Keep out of reach from children.

Tresivac Vaccine may not be given to newborns. First dose of Tresivac Vaccine is usually administered between 12 to 15 months and the second dose at 4 to 6 years of age.

Yes, it may be possible for the child to get an infection even after the vaccination, but the risk is low. However, vaccination is the best way to protect your child from these diseases. Always, follow the guidance of your doctor.

Tresivac Vaccine is administered at 12 months because it is most effective at that age. As the natural protection from the parent's antibodies starts to reduce over the first few months. The weakened viruses in the vaccine can multiply and cause an immune response.

Tresivac Vaccine causes side effects such as rash, low-grade fever, sore throat, runny nose, vomiting, diarrhoea, bleeding for longer than usual, redness near application site, pain and swelling. Please, contact a doctor if any of these side effects persist for longer durations.